- Home
- ADXN vs CMND Comparison
ADXN vs CMND Comparison
Compare ADXN & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- CMND
- Stock Information
- Founded
- ADXN 2002
- CMND 2017
- Country
- ADXN Switzerland
- CMND Canada
- Employees
- ADXN N/A
- CMND N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- CMND Health Care
- Exchange
- ADXN Nasdaq
- CMND Nasdaq
- Market Cap
- ADXN 8.0M
- CMND 6.5M
- IPO Year
- ADXN N/A
- CMND N/A
- Fundamental
- Price
- ADXN $7.52
- CMND $1.29
- Analyst Decision
- ADXN Strong Buy
- CMND
- Analyst Count
- ADXN 1
- CMND 0
- Target Price
- ADXN $30.00
- CMND N/A
- AVG Volume (30 Days)
- ADXN 11.6K
- CMND 91.1K
- Earning Date
- ADXN 03-24-2025
- CMND 04-15-2025
- Dividend Yield
- ADXN N/A
- CMND N/A
- EPS Growth
- ADXN N/A
- CMND N/A
- EPS
- ADXN 0.06
- CMND N/A
- Revenue
- ADXN $701,260.00
- CMND N/A
- Revenue This Year
- ADXN N/A
- CMND N/A
- Revenue Next Year
- ADXN N/A
- CMND N/A
- P/E Ratio
- ADXN $0.96
- CMND N/A
- Revenue Growth
- ADXN N/A
- CMND N/A
- 52 Week Low
- ADXN $6.67
- CMND $0.95
- 52 Week High
- ADXN $27.90
- CMND $2.30
- Technical
- Relative Strength Index (RSI)
- ADXN 48.90
- CMND 40.62
- Support Level
- ADXN $6.67
- CMND $1.35
- Resistance Level
- ADXN $7.80
- CMND $1.38
- Average True Range (ATR)
- ADXN 0.39
- CMND 0.09
- MACD
- ADXN 0.04
- CMND -0.01
- Stochastic Oscillator
- ADXN 62.04
- CMND 22.19
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.